| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.008 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.41 | 0.009 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |